News Out !!!........Right to the point shareholder
Post# of 7769
Posted On: 11/25/2014 8:27:11 AM
News Out !!!........Right to the point shareholders:>
ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
TYSONS CORNER, VA, Nov 25, 2014 (Marketwired via COMTEX) -- ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
During these interviews, Mr. Schneiderman provides commentary on ScripsAmerica's current operations and significant growth in 2014 as well as expectations for continued growth in the coming year. The investment community can access ScripsAmerica's CEO interview with 'Stock News Now' (SNN) here and the Company's interview with 'New to the Street' (NTTS) here.
Topics discussed by ScripsAmerica's CEO during his recent interviews include:
-- Significant revenue growth of the Company's wholly owned subsidiary,
Main Avenue Pharmacy.
-- The rapidly strengthening financial state of ScripsAmerica which
generated a profit during the 3rd quarter of 2014, has very high
profit margins in its compounding business and plans to eliminate any
further dilution of its stock for financing purposes moving forward.
-- The competitive advantages of compounding prescription creams for
treatment versus traditional oral delivery of medication in pill form
and the tremendous growth potential for this area of ScripsAmerica's
business.
ScripsAmerica would like to remind the investment community that the Company will host a conference call on Wednesday, December 3, 2014 at 10 a.m. Eastern Time. Senior management will discuss the Company's 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
StockNewsNow.com (SNN) is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia information hub for microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles.
New to the Street (NTSS) is a television show that profiles public companies, advertises and markets their products and services, and provides business news. NTSS offers a blend of business and financial services news reporting and in-depth interviews relating to new products, economic analysis and public company profiles.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.
Contact:
Seal Point Consulting
888-959-7095
Email Contact
ScripsAmerica Highlights CEO Interviews From Recent Investor Conference
TYSONS CORNER, VA, Nov 25, 2014 (Marketwired via COMTEX) -- ScripsAmerica Inc. (OTCBB: SCRC), today announced that its CEO, Bob Schneiderman, recently conducted interviews with financial outlets 'Stock News Now' (SNN) and 'New to the Street' (NTTS) at the SeeThru Equity Conference in NY.
During these interviews, Mr. Schneiderman provides commentary on ScripsAmerica's current operations and significant growth in 2014 as well as expectations for continued growth in the coming year. The investment community can access ScripsAmerica's CEO interview with 'Stock News Now' (SNN) here and the Company's interview with 'New to the Street' (NTTS) here.
Topics discussed by ScripsAmerica's CEO during his recent interviews include:
-- Significant revenue growth of the Company's wholly owned subsidiary,
Main Avenue Pharmacy.
-- The rapidly strengthening financial state of ScripsAmerica which
generated a profit during the 3rd quarter of 2014, has very high
profit margins in its compounding business and plans to eliminate any
further dilution of its stock for financing purposes moving forward.
-- The competitive advantages of compounding prescription creams for
treatment versus traditional oral delivery of medication in pill form
and the tremendous growth potential for this area of ScripsAmerica's
business.
ScripsAmerica would like to remind the investment community that the Company will host a conference call on Wednesday, December 3, 2014 at 10 a.m. Eastern Time. Senior management will discuss the Company's 10-Q filing for the third quarter ended September 30, 2014 and conduct a question and answer session.
StockNewsNow.com (SNN) is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia information hub for microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles.
New to the Street (NTSS) is a television show that profiles public companies, advertises and markets their products and services, and provides business news. NTSS offers a blend of business and financial services news reporting and in-depth interviews relating to new products, economic analysis and public company profiles.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.
Contact:
Seal Point Consulting
888-959-7095
Email Contact
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼